Imunon, Inc. Faces Delisting Concerns
Ticker: IMNN · Form: 8-K · Filed: Nov 27, 2024 · CIK: 749647
Sentiment: bearish
Topics: delisting, compliance, regulatory
TL;DR
Imunon's in trouble, might get delisted.
AI Summary
Imunon, Inc. filed an 8-K on November 27, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The company, formerly known as Celsion Corp, is based in Lawrenceville, NJ.
Why It Matters
This filing indicates potential issues with Imunon, Inc.'s ability to remain listed on an exchange, which could significantly impact its stock value and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's continued operation as a publicly traded entity, posing a significant risk to investors.
Key Players & Entities
- Imunon, Inc. (company) — Registrant
- Celsion Corp (company) — Former company name
- November 26, 2024 (date) — Earliest event reported
- November 27, 2024 (date) — Date of report
- Lawrenceville, NJ (location) — Principal executive office address
FAQ
What specific listing rule or standard has Imunon, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that Imunon, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated November 26, 2024.
What was Imunon, Inc.'s former company name?
Imunon, Inc. was formerly known as Celsion Corp.
Where are Imunon, Inc.'s principal executive offices located?
Imunon, Inc.'s principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311.
What is the Commission File Number for Imunon, Inc.?
The Commission File Number for Imunon, Inc. is 001-15911.
Filing Stats: 941 words · 4 min read · ~3 pages · Grade level 14.3 · Accepted 2024-11-27 16:30:38
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share IMNN Nasdaq Capital Mark
- $1.00 — mmon stock had closed below the minimum $1.00 per share requirement for continued lis
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001493152-24-048008.txt ( ) — 210KB
- imnn-20241126.xsd (EX-101.SCH) — 3KB
- imnn-20241126_lab.xml (EX-101.LAB) — 33KB
- imnn-20241126_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IMUNON, INC. Dated: November 27, 2024 By: /s/ Susan Eylward Susan Eylward General Counsel and Corporate Secretary